30 Oct, 2003Bausch & Lomb Upgrades Supply Chain
You are here:
30 Oct, 2003Bausch & Lomb Upgrades Supply Chain
20 Oct, 2003Zebra Supports FDA Report on Counterfeit Pharmaceuticals
Zebra Technologies Welcomes FDA Stand on High-Tech Weapons to Combat Counterfeit Drugs The FDA’s “Counterfeit Drugs Questions and Answers” reports that 10% of the international drug supply is counterfeit with rates as high as 50% in some nations. While the FDA believes the US drug supply is safe, it is working proactively to develop countermeasures […]
07 Oct, 2003Counterfeit Drug Protection
Princeton Junction, NJ, September 30, 2003 – Smart cards have a unique capability to make information access easier for users while at the same time enforcing the more robust security and privacy policies required of health care organizations to bring their environments into HIPAA compliance, according to a new Smart Card Alliance white paper released […]
26 Sep, 2003Protecting the Drug Supply
USATODAY.com – U.S. drug supply a terrorism target? “Technology “fixes” to thwart counterfeiting will also be outlined. Some drugmakers are embracing technologies, such as color-shifting inks on packages or radio-frequency identification tags, which can be used to track drugs from factory to pharmacy. “Technology can only go so far,” says Howard Koch, a director at […]
18 Sep, 2003Beverly, Addison Gilbert Hospitals Launch Health Card Technologies’ Smart Card Program
BEVERLY, Mass.–(BUSINESS WIRE)–Sept. 17, 2003–Beverly Hospital and Addison Gilbert hospital patients are receiving medical smart cards as part of a program designed to make hospital registration faster and more efficient. With nearly 500,000 cards to be distributed in the next 12 months, they are the first private hospitals in the United States to issue smart […]
17 Sep, 2003Maple Grove Tracks Medical Device
INDUSTRYWEEK’S BEST PLANTS “All of this bodes well for the U.S. launch of the drug-eluting stent. Still, pharmaceuticals are unfamiliar ground. To fulfill strict traceability requirements, rather than having two people doing the job of one, each signing off on the other’s work as is frequently done in pharmaceuticals, Maple Grove will track each stent […]
Enter the site